View Press Releases
-
1upHealth Launches 1up Clinical Connect to Help Payers Strengthen HEDIS Scores, Star Ratings, and Financial Performance with Continuous Clinical Data
Aug 31, 2026
-
Watchmaker Genomics Expands Boulder Manufacturing Campus to More Than Double Manufacturing Capacity
Watchmaker Genomics, a developer and manufacturer of precision reagents for genomics and molecular diagnostics, today announced that it has signed a long-term lease for approximately 100,000 square feet at Flatiron Park in Boulder, Colorado.
Aug 31, 2026
-
PharmaForceIQ Launches Optichannel 360, the First AI-Native Answer-to-Action Engine for Pharma Commercial Teams
PharmaForceIQ has today introduced Optichannel 360, an AI-native commercial execution platform that connects field and digital marketing, including a new measurement answer-to-action workflow.
Aug 25, 2026
-
Symbiosis strengthens commercial team with appointment of Jay Chima
Aug 25, 2026
-
Switchboard Health Acquires Livara Health to Integrate Value-Based Musculoskeletal Care
Aug 24, 2026
-
Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials
New START site to be established within AHN Cancer Center will integrate novel oncology research therapies closer to patients across Western Pennsylvania.
Aug 24, 2026
-
Carterra Enables Anthropic's Autonomous AI Protein Design Study via its HT-SPR Binding Platforms
Twist Bioscience and Adaptyv Bio used Carterra HT-SPR platforms to measure 1,320 protein binders against 15 targets designed by Anthropic's Claude models
Aug 23, 2026
-
Inovalon, UST, and AXIOM Systems join 1upHealth’s Partner Program
Aug 19, 2026
-
MEDPHARM EXPANDS END-TO-END PROTEOMIC ANALYSIS CAPABILITIES WITH OLINK® CERTIFICATION
MedPharm has become an Olink® Certified Service Provider (CSP), making it the first Olink CSP in the Carolinas and one of only three in the Southeastern United States. The new capability enables MedPharm to provide Olink proteomic analysis of multi-species samples across a range of matrices, including tissue, plasma, serum and tears, supporting clients from early research through clinical development. The certification expands MedPharm into targeted, multiplex protein biomarker analysis and complements its established disease modeling and human tissue-based research capabilities.
Aug 19, 2026
-
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Qureight today announced the opening of its new office space in London, UK. The expansion into a second site will accommodate the Company’s ongoing recruitment and platform technology development, to meet demand for its imaging CRO services across a broader range of lung and heart diseases.
Aug 18, 2026
-
Thomas Scientific Names Jeff Hrush Senior Vice President, Technical Sales
Thomas Scientific today announced that Jeff Hrush has joined the company as Senior Vice President, Technical Sales.
Aug 19, 2026
-
Prescient completes integration of Uptake and Dolon under single global brand
Aug 16, 2026
-
Amprion Partners with MLM Medical Labs to Expand Alpha-Synuclein SAA Testing in Europe
Amprion has announced a strategic licensing collaboration with MLM Medical Labs to expand access to alpha-synuclein seed amplification assay (SAA) testing for biopharma-sponsored clinical trials across Europe. Under the agreement, MLM will validate and perform Amprion's proprietary SAA methodology at its laboratory in Germany, supporting biomarker-driven neurodegenerative disease research and multinational clinical trials. The collaboration is intended to improve patient characterization and accelerate drug development for disorders such as Parkinson's disease, Lewy body dementia, and multiple system atrophy, while further expanding Amprion's international research capabilities.
Aug 11, 2026
-
CPHI launches new Sustainability Summit as pharma faces growing pressure to deliver sustainability goals
Aug 12, 2026
-
Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development
• Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows • Researchers invited to gain early access to platform and support ongoing product development
Aug 9, 2026
-
ECI’s Product & Packaging Testing Laboratory Achieves ISO/IEC 17025 Accreditation
ECI announced today that its Product & Packaging Testing Laboratory, located in the Coyol Free Zone in Costa Rica, has achieved ISO/IEC 17025:2017 accreditation from A2LA for technical competence in mechanical testing.
Aug 10, 2026
-
Sanofi’s MenQuadfi Wins EU Approval for Infants from Six Weeks Against Meningococcal Disease
Sanofi’s MenQuadfi has received European Commission approval for use in infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y. The expanded indication is supported by the MET58 pivotal study and clinical data involving more than 6,000 infants across 11 countries. The approval provides EU healthcare professionals with another option for early protection against a rapidly progressing and potentially fatal infection.
Aug 9, 2026
-
Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan
Regulatory milestone advances Proscia’s open approach to digital pathology
Aug 5, 2026
-
CellCarta Adds Tempus to CDx Commercialization Lab Network
CellCarta today announced a strategic collaboration with Tempus AI, Inc. (NASDAQ: TEM).
Aug 5, 2026
-
Inizio Launches Connected Insights to Transform Global Medical Information
Jul 27, 2026


